Shengfu Huang

484 total citations
27 papers, 344 citations indexed

About

Shengfu Huang is a scholar working on Surgery, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shengfu Huang has authored 27 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Otorhinolaryngology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shengfu Huang's work include Head and Neck Cancer Studies (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Head and Neck Surgical Oncology (7 papers). Shengfu Huang is often cited by papers focused on Head and Neck Cancer Studies (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Head and Neck Surgical Oncology (7 papers). Shengfu Huang collaborates with scholars based in China, Taiwan and United States. Shengfu Huang's co-authors include Xia He, Xuesong Jiang, Jianhua Xu, Wenjie Guo, Xiongying Miao, Xiuhua Bian, Lirong Wu, Yiqin Zhang, Dan Song and Ning Jiang and has published in prestigious journals such as Scientific Reports, Annals of Oncology and Journal of Endodontics.

In The Last Decade

Shengfu Huang

24 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengfu Huang China 11 152 122 98 86 79 27 344
Xing‐Li Yang China 12 175 1.2× 101 0.8× 75 0.8× 122 1.4× 53 0.7× 23 315
Jinming Yu China 11 55 0.4× 43 0.4× 186 1.9× 136 1.6× 80 1.0× 25 328
Daniela Paccagnella Italy 8 154 1.0× 110 0.9× 81 0.8× 150 1.7× 84 1.1× 11 361
A. Caldara Italy 9 70 0.5× 71 0.6× 124 1.3× 172 2.0× 52 0.7× 26 309
Aditya Shenoy United Kingdom 9 45 0.3× 46 0.4× 169 1.7× 108 1.3× 189 2.4× 11 515
Miho Kawashima Japan 9 18 0.1× 37 0.3× 113 1.2× 54 0.6× 34 0.4× 33 293
Jiaying Deng China 13 19 0.1× 260 2.1× 271 2.8× 158 1.8× 72 0.9× 40 447
M Botturi Italy 8 17 0.1× 46 0.4× 161 1.6× 102 1.2× 85 1.1× 18 309
Kevin Lee Min Chua Singapore 10 13 0.1× 40 0.3× 211 2.2× 141 1.6× 52 0.7× 30 341
Matthias Schauer Germany 10 10 0.1× 141 1.2× 178 1.8× 114 1.3× 95 1.2× 24 332

Countries citing papers authored by Shengfu Huang

Since Specialization
Citations

This map shows the geographic impact of Shengfu Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengfu Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengfu Huang more than expected).

Fields of papers citing papers by Shengfu Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengfu Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengfu Huang. The network helps show where Shengfu Huang may publish in the future.

Co-authorship network of co-authors of Shengfu Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Shengfu Huang. A scholar is included among the top collaborators of Shengfu Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengfu Huang. Shengfu Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Huang, Shengfu, et al.. (2020). Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma. Analytical Cellular Pathology. 2020. 1–10. 10 indexed citations
4.
Huang, Shengfu, et al.. (2020). Recommendation regarding the cranial upper border of level IIb in delineating clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiation Oncology. 15(1). 270–270. 3 indexed citations
5.
Li, Jiequn, Zhulin Yang, Shengfu Huang, & Daiqiang Li. (2020). BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma. Technology in Cancer Research & Treatment. 19. 1079239324–1079239324. 9 indexed citations
6.
Gu, Dayong, Shengfu Huang, Dan Zong, et al.. (2019). Clinical value of magnetic resonance diffusion-weighted imaging in early diagnosis and treatment of cervical lymph node recurrence after radiotherapy of nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 28(8). 571–574. 1 indexed citations
7.
Liu, Rushi, Zhulin Yang, Shengfu Huang, et al.. (2019). The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances. Surgical Oncology. 29. 41–47. 6 indexed citations
8.
Wu, Lirong, Jianhua Xu, Xuesong Jiang, et al.. (2018). Effectiveness of Cetuximab in Combination with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A 1:2 Propensity Score-matched Analysis. Journal of Cancer. 9(9). 1642–1651. 9 indexed citations
11.
Zhang, Lanfang, et al.. (2016). Upper bound of IIb region in clinical target volume for intensity-modulated radiotherapy for nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 25(11). 1151–1155. 2 indexed citations
12.
Huang, Shengfu, Zhulin Yang, Daiqiang Li, et al.. (2016). Jagged1 and DLL4 expressions in benign and malignant pancreatic lesions and their clinicopathological significance. Hepatobiliary & pancreatic diseases international. 15(6). 640–646. 12 indexed citations
13.
Lee, Tsair-Fwu, et al.. (2016). LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma. Scientific Reports. 6(1). 26378–26378. 39 indexed citations
14.
15.
Zhang, Rui, Shengfu Huang, Li Wang, & Bin Peng. (2014). Histochemical Localization of Dickkopf-1 in Induced Rat Periapical Lesions. Journal of Endodontics. 40(9). 1394–1399. 9 indexed citations
16.
Xu, Jianhua, Xia He, Wenjie Guo, et al.. (2013). Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: Survival and toxicity. Head & Neck. 36(10). 1474–1480. 20 indexed citations
17.
Li, Qiang, et al.. (2013). Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance. Clinical & Translational Oncology. 15(10). 818–824. 18 indexed citations
18.
Xie, Chengzhi, Guoxing Liu, Fu‐Sheng Wang, et al.. (2012). Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells. Oncology Letters. 4(3). 403–407. 11 indexed citations
19.
Yang, Zhi, Li Xiong, Shengfu Huang, et al.. (2011). Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder. Applied immunohistochemistry & molecular morphology. 19(6). 534–539. 8 indexed citations
20.
Miao, Xiongying, et al.. (2010). Anatomic mesohepatectomy with extrahepatic control of hepatic veins.. PubMed. 56(96). 1730–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026